New York State Common Retirement Fund
APLS

New York State Common Retirement Fund’s Apellis Pharmaceuticals APLS Stock Holding History

New York State Common Retirement Fund’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-84,451
Closed -$3.4M – 3184
2026
Q1 		$3.4M Sell
84,451
-19,567
-19% -$422K ﹤0.01% 1159
2025
Q4 		$2.61M Buy
104,018
+55,181
+113% +$1.29M ﹤0.01% 1297
2025
Q3 		$1.11M Sell
48,837
-10,042
-17% -$234K ﹤0.01% 1647
2025
Q2 		$1.02M Buy
58,879
+10,042
+21% +$186K ﹤0.01% 1653
2025
Q1 		$1.07M Hold
48,837
– – ﹤0.01% 1606
2024
Q4 		$1.56M Sell
48,837
-327,776
-87% -$9.86M ﹤0.01% 1506
2024
Q3 		$10.9M Sell
376,613
-54,500
-13% -$2.02M 0.01% 745
2024
Q2 		$16.5M Buy
431,113
+105,187
+32% +$4.76M 0.02% 586
2024
Q1 		$19.2M Sell
325,926
-14,581
-4% -$929K 0.03% 542
2023
Q4 		$20.4M Sell
340,507
-62,437
-15% -$3.17M 0.03% 526
2023
Q3 		$15.3M Buy
402,944
+101,949
+34% +$4.48M 0.02% 627
2023
Q2 		$27.4M Buy
300,995
+57,875
+24% +$4.99M 0.04% 440
2023
Q1 		$16M Buy
243,120
+138,700
+133% +$8M 0.02% 671
2022
Q4 		$5.4M Sell
104,420
-45,534
-30% -$2.42M 0.01% 1142
2022
Q3 		$10.2M Buy
149,954
+58,648
+64% +$3.47M 0.01% 834
2022
Q2 		$4.13M Buy
91,306
+13,615
+18% +$621K 0.01% 1287
2022
Q1 		$3.95M Buy
77,691
+11,877
+18% +$524K ﹤0.01% 1387
2021
Q4 		$3.11M Buy
65,814
+18,810
+40% +$741K ﹤0.01% 1534
2021
Q3 		$1.55M Sell
47,004
-20,761
-31% -$1.17M ﹤0.01% 1902
2021
Q2 		$4.28M Buy
67,765
+12,765
+23% +$659K ﹤0.01% 1409
2021
Q1 		$2.36M Sell
55,000
-7,685
-12% -$364K ﹤0.01% 1686
2020
Q4 		$3.59M Buy
62,685
+7,685
+14% +$325K ﹤0.01% 1385
2020
Q3 		$1.66M Hold
55,000
– – ﹤0.01% 1668
2020
Q2 		$1.8M Buy
55,000
+4,300
+8% +$138K ﹤0.01% 1577
2020
Q1 		$1.36M Buy
50,700
+7,300
+17% +$259K ﹤0.01% 1589
2019
Q4 		$1.33M Sell
43,400
-6,500
-13% -$180K ﹤0.01% 1811
2019
Q3 		$1.2M Buy
49,900
+400
+0.8% +$11K ﹤0.01% 1907
2019
Q2 		$1.25M Buy
49,500
+15,400
+45% +$313K ﹤0.01% 1907
2019
Q1 		$665K Hold
34,100
– – ﹤0.01% 2178
2018
Q4 		$450K Sell
34,100
-6,100
-15% -$93.6K ﹤0.01% 2335
2018
Q3 		$715K Hold
40,200
– – ﹤0.01% 2265
2018
Q2 		$884K Buy
40,200
+29,100
+262% +$669K ﹤0.01% 2165
2018
Q1 		$245K Buy
+11,100
New +$218K ﹤0.01% 2656

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund's APLS Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 84,451 shares — an estimated $3.4M sold.

New York State Common Retirement Fund first reported a position in APLS in Q1 2018 and held it in 33 quarters. The position peaked at $27.4M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 84,451 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.4M.
  • New York State Common Retirement Fund first reported a position in Apellis Pharmaceuticals in Q1 2018 and held it in 33 quarters.
  • New York State Common Retirement Fund's Apellis Pharmaceuticals position peaked at $27.4M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.